Search research articles

Search research articles

Related Experiment Videos

Vasodilator therapy.

The American Journal of Medicine

|February 28, 1986

Summary

This summary is machine-generated.

Vasodilator therapy, including nitrates and captopril, can improve symptoms of congestive heart failure. However, reduced mortality rates have not been proven, and predicting patient response remains challenging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators.

Pacing and clinical electrophysiology : PACE·1997

Same author

Modified technique for dual chamber pacemaker insertion.

Surgery, gynecology & obstetrics·1993

Same author

Sudden death associated with alcohol consumption.

Pacing and clinical electrophysiology : PACE·1988

Same author

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.

American heart journal·1987

Same author

Insidious onset of fatigue, dyspnea, and leg edema.

Archives of internal medicine·1985

Same author

Pericardial defect mimicking a left atrial mass.

The American journal of cardiology·1985

Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026

Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026

Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026

Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026

Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026

Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Area of Science:

Cardiology
Pharmacology

Background:

Congestive heart failure (CHF) management often requires advanced therapies when initial treatments are insufficient.
Vasodilators offer arteriolar or venous dilatation to address persistent CHF symptoms.

Purpose of the Study:

To evaluate the efficacy of vasodilator therapy in patients with persistent congestive heart failure symptoms.
To assess the impact of vasodilators on mortality rates in CHF.
To explore the predictability of clinical response to vasodilator treatment.

Main Methods:

Review of existing clinical data on vasodilator use in congestive heart failure.
Analysis of symptom improvement and mortality data associated with specific vasodilators like nitrates and captopril.

Related Experiment Videos

Main Results:

Nitrates and captopril demonstrate consistent symptomatic improvement in CHF patients.
No definitive reduction in mortality rates has been established with vasodilator therapy for CHF.
Clinical response to vasodilator therapy in CHF is difficult to predict.

Conclusions:

Vasodilators are valuable for symptom management in refractory congestive heart failure.
Current evidence does not support a mortality benefit from vasodilator therapy in CHF.
Further research is needed to improve the prediction of treatment response.